Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Observation of New Artificial Liver CABA System (BS330+CA280) in the Treatment of End-stage Liver Disease With Inflammation

NCT05780190 is registered in ClinicalTrials.gov with Qin Ning as lead sponsor.

NCT NCT05780190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05780190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Observation of New Artificial Liver CABA System (BS330+CA280) in the Treatment of End-stage Liver Disease With Inflammation
Lead sponsor
Qin Ning
Phase
Phase 4
Overall status
Unknown status
Start date
March 10, 2023
Completion date
March 8, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to evaluate the clinical efficacy and safety of the new alss